Patient Empowerment Leaps Forward in Latest Innovations

Dear Healthcare Innovators ♥️

We are extremely thankful for our readers and we want to wish you a Happy Thanks Giving! 🦃 We also want to mention that we have a Job Board coming soon. If you want to submit a job just click here

Sponsor Pulse Disruption | New Here? Subscribe!

🌐 Healthcare x Tech

University of Houston Graduate Honored for Open-Source 3D-Printed Finger Prosthesis

University of Houston graduate David Edquilang earned top international acclaim for Lunet, his durable yet elegantly simple 3D-printable prosthetic finger. By minimizing complexity and utilizing flexible linkages, Lunet advances function and affordability. Its design is open-source to aid underinsured amputees.

Created under UH's architecture and industrial design programs, versatile Lunet snagged multiple awards. But most rewarding for Edquilang is the profound impact on users’ lives. Alongside Lunet, UH researchers also made strides this year with an inconspicuous health-tracking interface and sensory-substituting haptics.

Edquilang’s prosthesis philosophy: Great ideas should be freely available, not products. By sharing Lunet globally, he epitomizes how UH ingenuity uplifts communities. Open-access 3D printing now puts high-performance prostheses within reach for countless limb-different people.

Read More +

Home Medical Devices Set to Transform Aging Population's Healthcare

Home-based connected devices are gaining traction as an empowering way for aging populations to independently monitor health in real time. With 65+ populations ballooning and healthcare systems overburdened, remote patient monitoring offers a convenient preventative solution.

Devices that unobtrusively track key biomarkers allow earlier intervention while reducing hospital stays. They also enable seniors to live actively while offering caregivers and clinicians up-to-date vitals. COVID-19 further demonstrated feasibility and fueled development.

Consumer preference also backs this patient-centric shift. Innovations from smart medication dispensers to medical robots cater to diverse needs. With ongoing investments and research into user-friendly, reliable offerings, home-based devices promise more accessible, proactive healthcare for all.

Read More +

💰  Healthcare x Startups

Sanguine Biosciences Secures $10M to Advance Cell and Gene Therapy Research and Manufacturing: Sanguine Biosciences, a StartUp Health company, secured $10 million in credit financing from Catalio Capital Management to support its apheresis donation center, develop cell and gene therapy products, and fund commercial growth.

Gynesonics Raises $42.5M to Develop Minimally-Invasive Solutions for Fibroids: Gynesonics, a Redwood City, CA-based healthcare company, raised $42.5 million from a Series C funding round led by Amzak Health. The funds will be used to support the development and commercialization of the company's minimally-invasive solutions for symptomatic uterine fibroids.

Engine Biosciences Raises $27M to Develop Precision Oncology Medicines: Engine Biosciences, a Singapore and Redwood City, CA-based company raised $27 million from a Series A funding round led by Polaris Partners. The funds will be used to support the development of the company's precision oncology medicines using machine learning to identify drug targets for cancer treatment.

Covera Health Raises $50M to Develop AI-Enabled Diagnostic Technology: Covera Health, a New York, NY-based AI-enabled diagnostic technology company, raised $50 million from a Series B funding round led by Coatue Management. The funds will be used to support the development and commercialization of AI-enabled diagnostic technology that uses artificial intelligence to analyze medical images.

2Morrow Bio Raises $50M to Develop New Approach to Treating Alzheimer's Disease: 2Morrow Bio, a South San Francisco, CA-based company, raised $50 million from a Series A funding round led by Fidelity Biosciences. The funds will be used to support the development of a new approach to treating Alzheimer's disease by targeting a protein that is thought to play a role in the disease.

Pear Therapeutics Raises $50M to Develop Digital Therapeutics for Mental Health: Pear Therapeutics, a Boston, MA-based company, raised $50 million from a Series E funding round led by Temasek and GV. The funds will be used to support the development and commercialization of digital therapeutics for mental health disorders, including schizophrenia, depression, and anxiety.

Big Health Raises $30M to Expand Access to Mental Health Care: Big Health, a San Francisco, CA-based company, raised $30 million from a Series C funding round led by Atomico and General Catalyst. The funds will be used to support the expansion of access to mental health care through its online platform, which offers cognitive behavioral therapy (CBT) and other evidence-based treatments.

Hinge Health Raises $27M to Develop AI-Powered Musculoskeletal Rehabilitation Platform: Hinge Health, a San Francisco, CA-based company, raised $27 million from a Series B funding round led by Tiger Global Management. The funds will be used to support the development and commercialization of an AI-powered musculoskeletal rehabilitation platform that uses artificial intelligence to personalize treatment plans and track patient progress.

Somryst Raises $24M to Develop Novel Sleep Therapeutics: Somryst, a South San Francisco, CA-based company, raised $24 million from a Series A funding round led by Andreessen Horowitz. The funds will be used to support the development and commercialization of novel sleep therapeutics that target a specific brain circuit involved in sleep regulation.

TrialSpark Raises $20M to Develop Decentralized Clinical Trials Platform: TrialSpark, a San Francisco, CA-based company, raised $20 million from a Series A funding round led by Khosla Ventures. The funds will be used to support the development and commercialization of a decentralized clinical trials platform that uses technology to make it easier and more affordable to conduct clinical trials.

Houston Wins $4M to Launch Biomedical Innovation Hub

The NIH awarded Houston a $4M grant to establish the Research Evaluation and Commercialization Hub (REACH). This new initiative, spearheaded by the Gulf Coast Consortium academic network, aims to accelerate biomedical entrepreneurship.

By providing expert guidance across discovery phases, REACH helps researchers translate ideas into commercial products benefiting patients. Resources span specialties like immunotherapies, nanodelivery, mental health, and more. REACH also connects startups to the consortium's broader drug development infrastructure.

With nearly $1B in existing medical research funding yearly, Houston sees ripe opportunity to boost commercial translation. REACH leverages the city's impressive research assets to nurture startup growth. Streamlined commercialization support helps ensure innovations realize their full impact potential.

Read More +

🕰️ Blasts from the Past: This Week in Medical History

November 16, 1922: Insulin is first used to treat a patient with diabetes, marking a revolutionary breakthrough in the management of this chronic disease.

November 17, 1953: Jonas Salk announces the development of a polio vaccine, a significant milestone in the fight against this debilitating disease.

November 18, 1961: Dr. Christiaan Barnard performs the first heart transplant in South Africa, demonstrating the feasibility of this complex surgical procedure.

November 19, 1978: Louise Brown, the first IVF baby, is born in England, paving the way for assisted reproductive technologies.

November 20, 1982: Genentech successfully produces artificial insulin, providing a more reliable and accessible source of this essential hormone.

November 21, 1995: The FDA approves the first gene therapy treatment for severe combined immunodeficiency (SCID), opening up new avenues for genetic therapy.

November 22, 1997: Dolly the sheep, the first cloned mammal, is born in Scotland, highlighting the potential and ethical implications of cloning technology.

🤖 Healthcare x Nurses x More

Nurse-Led Podcast Fosters Connections, Growth at Leading Pediatric Heart Center 

Two nurses at Texas Children’s Hospital, the #1 pediatric cardiology center nationally, spearheaded an internal podcast aimed at enhancing culture, education, and team cohesion across 900+ multidisciplinary staff.

Dubbed “I Heart the Heart,” it spotlights employees, shares case studies, and offers nursing insights - spreading passion and know-how hospital-wide. Its nurse-driven approach epitomizes Texas Children’s commitment to compassion and innovation in caring for young heart patients.

Though podcasting novices, the co-host/creators taught themselves the necessary skills. Their grit helps bridge silos between inpatient and outpatient staff at the pioneering Heart Center as all seek to continuously improve. They encourage nurses everywhere to find creative avenues to better connect colleagues. Because passion and determination matter more than experience when reaching for the next level of care.

Read More +

Decoding Clinician Burnout: Insights and Solutions

In the dynamic landscape of healthcare, the persistent challenge of clinician burnout demands a closer look, unveiling surprising trends and potential solutions.

The Paradox of Clinician Burnout. In an era marked by unprecedented medical breakthroughs, the unexpected paradox emerges: heightened dissatisfaction and a notable exodus of physicians. Astonishingly, 71,309 doctors left the profession last year alone, shedding light on the urgent need for addressing burnout.

Global Trends: Is Burnout Distinctly American? Contrary to assumptions, U.S. primary care physicians report mid-range burnout, challenging the belief that burnout is an exclusive woe of the American healthcare system. Insights from the Commonwealth Fund reveal a more complex global scenario.

Chronic Disease Impact. A seismic shift in healthcare dynamics is evident as chronic diseases take center stage. No longer grappling solely with acute conditions, doctors face the relentless demands of patients with chronic illnesses, contributing significantly to workplace dissatisfaction.

Rethinking Burnout: Beyond Bureaucracy. While bureaucratic challenges undoubtedly play a role, a profound rethink suggests that the evolution of diseases itself might be a crucial factor in clinician dissatisfaction. The term "moral injury" captures the pain physicians experience when circumstances force compromises in patient care.

Tech-Driven Solution: A Glimmer of Hope. Amid these challenges, a promising tech-driven solution emerges. Envisioning a future where a 30% reduction in chronic diseases transforms the daily workload for physicians, innovative technologies offer a beacon of hope for a resilient and fulfilling healthcare system.In the dynamic landscape of healthcare, the persistent challenge of clinician burnout demands a closer look, unveiling surprising trends and potential solutions.

The Paradox of Clinician Burnout. In an era marked by unprecedented medical breakthroughs, the unexpected paradox emerges: heightened dissatisfaction and a notable exodus of physicians. Astonishingly, 71,309 doctors left the profession last year alone, shedding light on the urgent need for addressing burnout.

Global Trends: Is Burnout Distinctly American?. Contrary to assumptions, U.S. primary care physicians report mid-range burnout, challenging the belief that burnout is an exclusive woe of the American healthcare system. Insights from the Commonwealth Fund reveal a more complex global scenario.

Chronic Disease Impact. A seismic shift in healthcare dynamics is evident as chronic diseases take center stage. No longer grappling solely with acute conditions, doctors face the relentless demands of patients with chronic illnesses, contributing significantly to workplace dissatisfaction.

Rethinking Burnout: Beyond Bureaucracy. While bureaucratic challenges undoubtedly play a role, a profound rethink suggests that the evolution of diseases itself might be a crucial factor in clinician dissatisfaction. The term "moral injury" captures the pain physicians experience when circumstances force compromises in patient care.

Tech-Driven Solution: A Glimmer of Hope. Amid these challenges, a promising tech-driven solution emerges. Envisioning a future where a 30% reduction in chronic diseases transforms the daily workload for physicians, innovative technologies offer a beacon of hope for a resilient and fulfilling healthcare system.

Read More +

🧠 Healthcare x AI

GE HealthCare Leverages AI Technology to Enhance Healthcare Data Utilization and Clinical Precision

GE HealthCare (GEHC) is poised to showcase its advanced AI technology at RSNA 2023, emphasizing its efforts to transform untapped healthcare data into valuable insights that empower providers to optimize patient care. Recognizing the vast potential of healthcare data, GEHC highlights that approximately 30% of the world's data is generated by the healthcare industry, yet a staggering 97% of data produced by hospitals remains underutilized.

To address this challenge, GEHC will unveil its App Orchestrator, a versatile application orchestration solution that grants seamless access to a diverse range of applications from multiple vendors. Additionally, the company will introduce CardioVisio, an AI-powered AFiB patient management dashboard designed to streamline clinical workflows, bolster diagnostic confidence, and deliver personalized care. GEHC's commitment to AI innovation is further underscored by its position atop the U.S. Food and Drug Administration (FDA) list of AI-enabled medical devices. To date, the company has garnered 58 510(k) clearances or authorizations.

Furthermore, GEHC is collaborating with Nuance and Microsoft on a groundbreaking research project aimed at automatically compiling relevant prior reports and summarizing key findings for radiologists within the imaging workflow. GEHC's AI-driven initiatives exemplify the company's dedication to transforming healthcare data into actionable insights, empowering providers to deliver more effective and personalized care.

Read More +

🌎  Healthcare x LATAM

$5M Grant Fuels Cancer Control Innovation Across Mexico, Latin America

The National Cancer Institute awarded $5M to a coalition spearheaded by UTHealth Houston and including Mexican/Latin partners. They established the LISTOS center to optimize real-world implementation of evidence-based cancer interventions, enhancing regional impact and equity.

Initial projects address early colorectal screening/detection and rapid breast cancer diagnosis targeting health system gaps. By studying localized barriers, LISTOS develops culturally-tailored strategies to sustainably translate proven approaches into practice. Training next-gen implementation scientists also strengthens regional expertise.

With cancer control lagging real-world adoption of available knowledge, LISTOS leverages implementation science to forge progress. As the only NCI-backed hub focused wholly on Latin America/Caribbean, its mandate supports lasting regional advances against dire cancer disparities.

Read More +

That’s all for this week.
The Pulse Disruption Team